New clues to how the tumor microenvironment impacts pancreatic cancer

GOT2 causes metabolic changes that pancreas tumors overcome.

10:13 AM

Author | Nicole Fawcett

Within a pancreatic cancer tumor, different cell types interact to facilitate the tumor's growth. Researchers see disrupting this metabolic crosstalk as a compelling target for treatment.

In a new study published in eLife, researchers from the University of Michigan Rogel Cancer Center looked at the mitochondrial metabolism, which is key driver of pancreatic cancer.

By looking at cell lines, they found loss of the mitochondrion GOT2 causes metabolic changes that impair cellular growth. But in engineered mice, loss of GOT2 had no effect on tumor growth or initiation.

Cancer cells use a complex cell-intrinsic rewiring and crosstalk with the tumor microenvironment in vivo. These data emphasize an under-appreciated role for GOT2 in pancreatic tumor redox homeostasis and illustrate the way cancer cells use biochemical pathways and metabolic plasticity to grow in vivo.

The study was led by Samuel Kerk, who works in labs run by Rogel members Costas Lyssiotis, Ph.D., and Yatrik Shah, Ph.D.

"This work suggests the role of the tumor microenvironment should be considered when targeting cancer metabolism," the authors wrote. "Targeting pancreatic cancer metabolism is an alluring approach, and a more detailed understanding of the metabolic crosstalk occurring in a pancreatic tumor can shed light on potential resistance mechanisms and inform more effective metabolic therapies."

Paper cited: "Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context," eLife. DOI: 10.7554/eLife.73245


More Articles About: Lab Notes Pancreatic cancer Basic Science and Laboratory Research Cancer Research Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories see through blue person with red lines running through neck to chest
Health Lab
What is phrenic neuropathy?
Phrenic neuropathy is a condition that impacts the nerve around the diaphragm making it harder to breathe, especially in situations such as lying down or being in water. The condition is treatable, with surgical intervention, physical therapy or by letting it heal over time.
Microscope
Health Lab
Nerve damage reduced in prediabetic mice with diet, exercise
A low calorie diet and high intensity exercise can reduce nerve damage in prediabetic mice, according to a Michigan Medicine study.
frozen dial with ice on it with red dial
Health Lab
Enzyme identified as new therapeutic target for “cold” tumors
A study identifies an enzyme as a new therapeutic target for “cold” tumors.
three friends standing outside rogel cancer center building with big white ribbons
Health Lab
A lung cancer survivor shaping lung cancer advocacy
One woman's unexpected lung cancer diagnosis leads her to help many who aren't aware they're at risk of the disease.
cell formation in grey and then two circles highlighed blue and one red
Health Lab
The solution to death from a fentanyl overdose could lie in its chemical structure
University of Michigan researchers may have found that the solution to prevent people from dying from a fentanyl overdose may be found within fentanyl's own chemistry.
close up of orange and purple squiggle-looking cells merging and a little green in the middle
Health Lab
Researchers find metabolic mechanism that blocks immune response, immunotherapy in cancer
New research has discovered why some cancers don’t respond to immunotherapy treatment: A metabolite transporter within the tumor microenvironment blocks a key type of tumor cell death integral to immune response.